Health TrialsbyHealthPanel

Triage Radiology Imaging Assessment for Greater Effectiveness

ConditionBrain
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKing's College London

About this trial

The aim of the trial is to understand whether a computerised tool designed to quickly spot problems in brain scans (MIDI) can help doctors diagnose cases faster. This will help patients by getting them the treatment they need sooner. How useful doctors find the tool will also be measured, and whether it is cost-saving for the National Health Service (NHS).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patient (≥ 18 years of age) at the time of MRI.

Brain MRI scan performed at a participating NHS site during the defined study period (intervention or control arm).

Brain MRI scan series will automatically be included if they contain the required scan sequences and are of the required resolution.

Adult patient (≥ 18 years of age) at the time of MRI.

Disqualifiers

Patient is under 18 years of age at the time of MRI.

Brain MRI scan not performed at a participating NHS site or outside the defined study period.

Data will be excluded for those patients who have opted out of the use of their data for research under the National Data Opt-Out.

Brain MRI scan series will automatically be excluded if they do not contain the required scan sequences and/or the required resolution.

Trial design

Design model

Crossover

Treatments tested in this trial

  • MIDI

    Device

    MIDI is an AI-based TRIAGE tool and its primary purpose is workflow triage of brain MRI scans.

Treatment groups

100,800 Participants
are divided into 2 treatment groups
Group A: Intervention - MIDI ONExperimental treatment 1 intervention
Group B: Control - MIDI OFFNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Turnaround time for abnormal outpatient brain MRI scans

Time frame
Time from abnormal MRI acquisition to radiologist report authorisation over 8 months.

Secondary outcomes

1

Turnaround time for abnormal inpatient brain MRI scans

Time frame
Time from abnormal MRI acquisition to radiologist report authorisation over 8 months.
2

Turnaround time for abnormal combined Brain MRI scans

Time frame
Time from abnormal MRI acquisition to radiologist report authorisation over 8 months.
3

Cost Effectiveness - Incremental cost per reduction in brain MRI scan turnaround time, radiologist reporting time, insourcing/outsourcing of reporting activity

Time frame
From MRI scan acquisition to final radiologist report authorisation over 8 months.
4

Cost Effectiveness for patients with suspected TIA or Stroke - incremental cost per reduction in brain MRI turnaround time, time to diagnosis and time to treatment change

Time frame
From MRI scan acquisition to initiation of treatment over 8 months.

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

King's College London

Lead sponsor

Queen Mary University of London

Collaborator

The Leeds Teaching Hospitals NHS Trust

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: